Mammogram providers will be required to inform women with dense breast tissue that their cancer screenings may be difficult to interpret and recommend consulting their doctors about the need for additional tests, the Food and Drug Administration announced.
breast density risks and potentially detect cancer earlier. Providers must implement the new regulations within 18 months, the agency said.
that in 2023, about 297,790 women will be diagnosed with invasive breast cancer and some 43,700 will die of the disease.“Today’s action represents the agency’s broader commitment to support innovation to prevent, detect and treat cancer,” Hilary Marston, the FDA’s chief medical officer, said in a statement.
Some states currently tell women they have dense breasts, but nothing more, said JoAnn Pushkin, executive director of New York-based, a resource website that aims to teach patients and health-care professionals about dense breasts. Dense breasts have relatively less fatty tissue and higher amounts of glandular and fibrous connective tissue. Nearly half of all women 40 and over have the condition. Dense breasts can appear white on a mammogram — but so does cancer, making it difficult for radiologists to detect tumors.of getting breast cancer, according to the National Cancer Institute.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
EoE: One-Food Elimination Works as Well as Six-Food EliminationEliminating only milk not only reduced symptoms but also improved quality of life for patients with eosinophilic esophagitis. MedTwitter
Weiterlesen »
North Texas Food Bank food distribution events this weekThe North Texas Food Bank is holding several walk-up and drive through food giveaways this week.
Weiterlesen »
Albuterol Shortage Challenges Hospitals Treating Patients With Breathing ProblemsHospitals are running out of a liquid form of albuterol, a medication used to treat people with breathing problems, weeks after the only maker of the product declared bankruptcy
Weiterlesen »
Women Who Almost Died From Texas’ Abortion Ban Sue State in Landmark LawsuitThey're suing for clarity on the ban's exception for threats to the pregnant person's life. One of the women lost a fallopian tube; another is still pregnant.
Weiterlesen »
Republican states say the FDA doesn't have the authority to override state abortion pill bansThe Republicans argued that FDA approval of a drug does not give the manufacturer an unconditional right to the sell the medication at all times.
Weiterlesen »
FDA: Two more eyedrop brands recalled due to risksWASHINGTON (AP) — U.S. health officials are alerting consumers about two more recalls of eyedrops due to contamination risks that could lead to vision problems and serious injury. The announcements follow a recall last month of eyedrops made in India that were linked to an outbreak of drug-resistant infections. One person died and at least five others had permanent vision loss.
Weiterlesen »